Class I - Dangerous
Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein.